TAG:
Roche
May 26, 2026, Intelligence: Late-Breaking Lab News
By Janette Wider | From the Volume XXXIII, No. 7 – May 26, 2026 Issue
UnitedHealthcare is expanding rural healthcare initiatives that could provide operational relief for clinical laboratories in underserved communities. The effort focuses on improving cash flow, reducing administrative burdens, and strengthening financial stability for rural hospitals an…
Pathology Lab Opportunities for Biopharma Collaboration
By Stephen Beale | From the Volume XXXIII, No. 4 – March 23, 2026 Issue
As anatomic pathology laboratories face declining reimbursements and other challenges to their bottom lines, one possible solution could involve collaboration with biopharmaceutical companies. But what exactly are drug companies looking for, and how can labs forg…
Cuts to Rural Labs Boost RESULTS Act Support
By Scott Wallask | From the Volume XXXIII, No. 1 – January 19, 2026 Issue
CEO SUMMARY: Two related legislative concerns should have the sharp attention of clinical laboratory leaders, particularly those in rural areas. On one end, PAMA cuts are scheduled to hit on Jan. 31 short of another reprieve from Congress. Meanwhile, lawmakers at a recent …
Top Stories in 2025 Played Out in Courts, Capitol Hill
By Janette Wider | From the Volume XXXII, No. 18 – December 29, 2025 Issue
CEO SUMMARY: The biggest story of the year for clinical laboratories came in a huge court victory, as a federal judge vacated the FDA’s final rule on laboratory developed tests. Labs breathed a sigh of relief after the court decision, as the FDA rule had promised to incr…
Despite Trade Tariffs, IVD Firms Report Upbeat Earnings
By Mark Terry | From the Volume XXXII, No. 12 – August 25, 2025 Issue
LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manu…
Fast, $17.5B Deal Lands Waters Corp. in IVD Market
By Janette Wider | From the Volume XXXII, No. 11 – August 4, 2025 Issue
WHEN BECTON DICKINSON (BD) ANNOUNCED ITS INTENT to spin off its in vitro diagnostics (IVD) and life sciences units in February, few observers expected a deal to close just five months later. But now that such an agreement has occurred as of July 14, the buy…
July 14, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 10 – July 14, 2025 Issue
Clinical laboratories across the country that have not prepared for the potential of increased measles testing may want to consider doing so. On July 7, The Washington Post reported that US measles cases had reached a 33-year high, based on data collected by the Johns Hopkins Center for…
Leveraging Data to Create Lab and Healthcare Efficiencies
By Robert Michel | From the Volume XXXII, No. 8 – June 2, 2025 Issue
CEO SUMMARY: In this exclusive interview with The Dark Report, Bradley Bostic, founder, chair, and CEO of healthcare and laboratory data intelligence company hc1 discusses trends in healthcare, how to position clinical laboratories as a strategic asset, and ways to analyze…
September 23, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue
One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki t…
June 10, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 8 – June 10, 2024 Issue
Once a high-flier lab test manufacturer with a market valuation of $2 billion, Cue Health of San Diego filed for Chapter 7 bankruptcy on May 28. Analysts now say the company is valued at about $15 million. Founded in 2010, Cue Health was developing a test system that consumers could …
CURRENT ISSUE
Volume XXXIII, No. 8 – June, 2026
Congress Returns to CLIA Reform with Proposed LDT Framework, and the Newly Filed Enhancing CLIA Act seeks to modernize clinical laboratory regulations. A newly introduced federal bill could signal the next chapter in the long-running debate over how laboratory developed tests (LDTs) should be regulated in the United States.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized